Study endpoints after 30-day and 2-year follow-ups
| Variable | Immediate treatment | Delayed treatment | RR (95% CI) | p Value |
| 30-day follow-up | n=262 (%) | n=261 (%) | ||
| Combined incidence of death, reinfarction and recurrent ischaemia | 9.9 | 14.2 | 0.70 (0.43 to 1.12) | 0.14 |
| Death | 1.1 | 1.1 | 1.00 (0.20 to 4.89) | >0.99 |
| Reinfarction | 1.9 | 0.8 | 2.49 (0.49 to 12.72) | 0.45 |
| Recurrent ischaemia | 7.6 | 12.6 | 0.60 (0.36 to 1.02) | 0.06 |
| 2-year follow-up | n=262 (%) | n=259 (%) | ||
| Combined incidence of death or reinfarction | 11.8 | 13.1 | 0.90 (0.57 to 1.42) | 0.66 |
| Death | 6.1 | 8.9 | 0.69 (0.37 to 1.27) | 0.23 |
| Reinfarction | 6.5 | 5.4 | 1.20 (0.60 to 2.38) | 0.60 |
RR, relative risk.